by dave | Feb 18, 2021 | Uncategorized
by dave | Feb 26, 2020 | News, Schizophrenia
Are you a woman living with schizophrenia? We have several clinical trials that might be just right for you. The trials are compensated if you qualify, and transportation is provided. In addition, we provide standard of care treatment while you are in trial.... by dave | Feb 13, 2019 | Depression, News
Esketamine, a drug developed by Johnson & Johnson for the treatment of depression has received support from two FDA committees. Final FDA approval is expected by March 2019. The drug has been approved for use in treatment resistant depression. From the... by dave | Jan 30, 2019 | Depression, News
Are you currently experiencing the signs of major depression and don’t know where or how to get help? Perhaps you’ve experienced these symptoms before- starting early in your life- and you’re finding that each time to get depressed, it’s even... by dave | Jan 29, 2019 | Depression, News
Depression research study participants needed to take part in several clinical research trials exploring the effects of rapastinel, esketamine, and ketamine like compounds. Generally, research participants for these trials should: Be diagnosed with major depression Be...
